Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cells in solid cancers often reside in hypoxic (low oxygen) microenvironments due to abnormal vasculature and rapid proliferation. This hypoxia induces adaptive responses that promote tumor survival, progression, immune evasion, and resistance to therapy. Certain bacteria can invade tumor cells—especially within these hypoxic regions—further influencing tumor behavior and providing novel therapeutic opportunities.
Hypoxia-activated prodrug activation; HIF pathway inhibition; bacterial-mediated drug delivery; modulation of intratumoral microbiota.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell via hypoxic microenvironment and bacterial invasion.